399 related articles for article (PubMed ID: 12442660)
1. Functional neuroanatomy of the basal ganglia in Parkinson's disease.
Wichmann T; DeLong MR
Adv Neurol; 2003; 91():9-18. PubMed ID: 12442660
[No Abstract] [Full Text] [Related]
2. Parkinson's disease is a neuropsychiatric disorder.
Agid Y; Arnulf I; Bejjani P; Bloch F; Bonnet AM; Damier P; Dubois B; François C; Houeto JL; Iacono D; Karachi C; Mesnage V; Messouak O; Vidailhet M; Welter ML; Yelnik J
Adv Neurol; 2003; 91():365-70. PubMed ID: 12442695
[No Abstract] [Full Text] [Related]
3. Potential nondopaminergic drugs for Parkinson's disease.
Silverdale MA; Fox SH; Crossman AR; Brotchie JM
Adv Neurol; 2003; 91():273-91. PubMed ID: 12442686
[No Abstract] [Full Text] [Related]
4. The role of the subthalamic nucleus in the pathophysiology of Parkinson's disease.
Blandini F
Funct Neurol; 2001; 16(4 Suppl):99-106. PubMed ID: 11996537
[No Abstract] [Full Text] [Related]
5. Basal ganglia oscillations and pathophysiology of movement disorders.
Rivlin-Etzion M; Marmor O; Heimer G; Raz A; Nini A; Bergman H
Curr Opin Neurobiol; 2006 Dec; 16(6):629-37. PubMed ID: 17084615
[TBL] [Abstract][Full Text] [Related]
6. Implications of alterations in trace element levels in brain in Parkinson's disease and other neurological disorders affecting the basal ganglia.
Dexter DT; Sian J; Jenner P; Marsden CD
Adv Neurol; 1993; 60():273-81. PubMed ID: 8420143
[No Abstract] [Full Text] [Related]
7. Cortico-basal ganglia-cortical circuitry in Parkinson's disease reconsidered.
Braak H; Del Tredici K
Exp Neurol; 2008 Jul; 212(1):226-9. PubMed ID: 18501351
[TBL] [Abstract][Full Text] [Related]
8. Nondopaminergic neurons in Parkinson's disease.
Hirsch EC; Orieux G; Muriel MP; Francois C; Feger J
Adv Neurol; 2003; 91():29-37. PubMed ID: 12449099
[No Abstract] [Full Text] [Related]
9. Clinical and neurochemical consequences of neuronal loss in the nucleus basalis of Meynert in Parkinson's disease and Alzheimer's disease.
Whitehouse PJ
Adv Neurol; 1987; 45():393-7. PubMed ID: 2881448
[No Abstract] [Full Text] [Related]
10. Regulation of dopamine receptor and neuropeptide expression in the basal ganglia of monkeys treated with MPTP.
Betarbet R; Greenamyre JT
Exp Neurol; 2004 Oct; 189(2):393-403. PubMed ID: 15380489
[TBL] [Abstract][Full Text] [Related]
11. The basal ganglia circuits, dopamine, and ambiguous word processing: a neurobiological account of priming studies in Parkinson's disease.
Chenery HJ; Angwin AJ; Copland DA
J Int Neuropsychol Soc; 2008 May; 14(3):351-64. PubMed ID: 18419834
[TBL] [Abstract][Full Text] [Related]
12. Levodopa enhances synaptic plasticity in the substantia nigra pars reticulata of Parkinson's disease patients.
Prescott IA; Dostrovsky JO; Moro E; Hodaie M; Lozano AM; Hutchison WD
Brain; 2009 Feb; 132(Pt 2):309-18. PubMed ID: 19050033
[TBL] [Abstract][Full Text] [Related]
13. Understanding the dopaminergic deficits in Parkinson's disease: insights into disease heterogeneity.
Lewis SJ; Barker RA
J Clin Neurosci; 2009 May; 16(5):620-5. PubMed ID: 19285870
[TBL] [Abstract][Full Text] [Related]
14. Mapping neuronal activity of the basal ganglia in experimental models of Parkinson's disease: contributions of the [14C]2-deoxyglucose method.
Orzi F; Fornai F; Blandini F
Funct Neurol; 2000; 15(4):269-76. PubMed ID: 11213530
[No Abstract] [Full Text] [Related]
15. The basal ganglia in Parkinson's disease: current concepts and unexplained observations.
Obeso JA; Marin C; Rodriguez-Oroz C; Blesa J; Benitez-Temiño B; Mena-Segovia J; Rodríguez M; Olanow CW
Ann Neurol; 2008 Dec; 64 Suppl 2():S30-46. PubMed ID: 19127584
[TBL] [Abstract][Full Text] [Related]
16. [Movement disorders and basal ganglia function].
Dietrichs E
Tidsskr Nor Laegeforen; 2008 Sep; 128(17):1968-71. PubMed ID: 18787574
[TBL] [Abstract][Full Text] [Related]
17. Basic research on dopamine in Parkinson's disease and the discovery of the nigrostriatal dopamine pathway: the view of an eyewitness.
Hornykiewicz O
Neurodegener Dis; 2008; 5(3-4):114-7. PubMed ID: 18322366
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial energy crisis in Parkinson's disease.
Mizuno Y; Ikebe S; Hattori N; Kondo T; Tanaka M; Ozawa T
Adv Neurol; 1993; 60():282-7. PubMed ID: 8420144
[No Abstract] [Full Text] [Related]
19. Physiology and pathophysiology of the basal ganglia-thalamo-cortical networks.
Rosin B; Nevet A; Elias S; Rivlin-Etzion M; Israel Z; Bergman H
Parkinsonism Relat Disord; 2007; 13 Suppl 3():S437-9. PubMed ID: 18267279
[TBL] [Abstract][Full Text] [Related]
20. Dopamine receptors in the basal ganglia: relevance to Parkinson's disease.
Strange PG
Mov Disord; 1993 Jul; 8(3):263-70. PubMed ID: 8101967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
